Try our beta test site
61 studies found for:    NIAID | Open Studies | healthy
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Safety and Pharmacokinetics of a Single ZMappTM Administration in Healthy Adult Volunteers
Condition: Healthy
Intervention: Drug: ZMAPP
2 Recruiting Volunteer Screening for Vaccine and Antivirals Clinical Trials
Condition: Healthy Volunteer
Intervention:
3 Recruiting Evaluating the Safety of and Immune Response to a Dengue Vaccine (TV003) in Healthy Adults, Adolescents, and Children in Thailand
Condition: Dengue
Interventions: Biological: TV003;   Biological: Placebo for TV003
4 Recruiting Study in Healthy Volunteers to Evaluate the Efficacy and Safety of CR6261 in an H1N1 Influenza Healthy Human Challenge Model
Condition: H1N1 Influenza Healthy Volunteers
Interventions: Biological: CR6261;   Biological: Placebo
5 Recruiting Study of Safety and Immunogenicity of HIV Vaccines in Healthy Volunteers
Conditions: Healthy Volunteer;   HIV Vaccine
Interventions: Biological: Ad4-mgag;   Biological: Ad4-EnvC150
6 Recruiting Screening of Volunteers for Clinical Trials of Investigational or Licensed Vaccines or Antiviral Products
Condition: Healthy Volunteers
Intervention:
7 Recruiting Influenza A H3N2 Human Challenge Study in Healthy Adult Volunteers
Condition: Determine Minimally to Moderately Infective Dose (MMID) of Influenza A H3N2
Intervention: Other: Live recombinantly derived A/Bethesda/MM1/H3N2 virus
8 Recruiting Normal Immunological Parameters Among Healthy Volunteers in Kambila, Mali
Condition: Malaria
Intervention:
9 Recruiting Collection of Peripheral Blood and Bone Marrow From Healthy Donors for Use in In Vitro Research
Condition: Eosinophilia
Intervention:
10 Recruiting Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Condition: T-Lymphocytopenia, Idiopathic CD4-Positive
Intervention:
11 Recruiting Screening of Healthy Volunteers for Investigational Antimalarial Drugs, Malaria Vaccines, and Controlled Human Malaria Challenge
Condition: Malaria
Intervention:
12 Not yet recruiting Impact of Antimalarial Treatment on Measures of T Cell Suppression/Regulation in Healthy Adults From Doneguebougou, Mali
Condition: Malaria
Intervention:
13 Recruiting Randomized, Double-Blind, Placebo-Controlled, Phase 1 Study in Healthy Volunteers to Evaluate the Safety and Immunogenicity of AGS-v, a Universal Mosquito-Borne Disease Vaccine
Condition: Mosquito-Borne Disease
Interventions: Biological: AGS-v;   Biological: AGS-v + adjuvant;   Other: Placebo
14 Recruiting Dose, Safety, Tolerability and Immunogenicity of a Stabilized Prefusion RSV F Subunit Protein Vaccine, VRC-RSVRGP084-00-VP (DS-Cav1), Alone or With Alum Adjuvant, in Healthy Adults
Condition: Respiratory Syncytial Virus
Intervention: Biological: VRC-RSVRGP084-00VP
15 Recruiting Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB080-00-AB (VRC01LS), With Broad HIV-1 Neutralizing Activity, Administered Intravenously or Subcutaneously to Healthy Adults
Conditions: Prevention of HIV Infection;   HIV Antibodies;   Monoclonal Antibody, Human;   Neutralizing Antibody
Interventions: Biological: VRC-HIVMAB080-00-AB (VRC01LS);   Biological: VRC-HIVMAB060-00-AB (VRC01)
16 Recruiting Inflammatory Responses in Normal Volunteers and Patients With Abnormal Immune Responses
Conditions: Healthy Volunteers;   Abnormal Phagocyte Function
Intervention:
17 Recruiting VRC 605: A Phase 1 Dose-Escalation Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB075-00-AB (VRC07-523LS), Administered Intravenously or Subcutaneously to Healthy Adults
Condition: HIV Prevention
Intervention: Biological: VRC-HIVMAB075-00-AB
18 Not yet recruiting Study to Evaluate Safety and PK of NTM-1634 vs Placebo Administered Intravenously in Healthy Adults
Condition: Healthy
Interventions: Drug: NTM-1634;   Drug: Placebo
19 Recruiting Collection of Peripheral Blood Stem Cells Using G-CSF and Plerixafor in Normal Volunteers
Condition: Normal Volunteer
Intervention:
20 Recruiting VRC 320: A Phase I, Randomized Clinical Trial to Evaluate the Safety and Immunogenicity of a Zika Virus DNA Vaccine, VRC-ZKADNA090-00-VP, Administered Via Needle and Syringe or Needle-free Injector, PharmaJet, inHealthy Adults
Conditions: Prevention of Zika Infection;   Zika-Specific Immune Response
Intervention: Biological: VRC-ZKADNA090-00-VP

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.